Vienna,

LISAvienna event tip: Takeda R&D Science Day 2024

LISAvienna is happy to collaborate with Takeda and invites you to participate in the second Takeda R&D Science Day in Vienna on November 28, 2024. This is a great opportunity to both gain knowledge on innovations that are of interest to Takeda and to get feedback on CMC related products, services, and solutions, from the perspective of a global R&D player in the biopharmaceutical industry.

Takeda’s R&D Science Day 2024 will include up to 5 meeting slots in Vienna for informal exchange of non-confidential knowledge.

Who is invited to participate?

Takeda’s R&D Science Day 2024 focuses on start-ups, subject matter experts and application-oriented academic researchers from across Austria. Takeda is particularly interested in process development technologies for biopharmaceuticals, from new sensors to digital process control, automated solutions and robotics in the lab, as well as solutions for making process development more sustainable, i.e. using less raw material and minimizing carbon footprint. Technologies can range from prototype and proof-of-concept stages to ready-to-use solutions.

Please note that this is not a call for investment opportunities or strategic partnerships in early-stage drug development.

How to participate?

We ask you to submit non-confidential information in the form of 3-5 slides as well as 3-5 questions you would like to discuss with Takeda’s experts at RnD.Austria(at)takeda.com 

Mark your calendar:

  • October 24, 2024: Submission deadline for your files to Takeda
  • November 14, 2024: Decision sent to finalists.
  • November 28, 2024: Takeda R&D Science Day with individual meeting slots

About Takeda in Austria

In Austria, Takeda works along the entire pharmaceutical value chain: Research & Development, Plasma Sourcing, Manufacturing and Patient Access. Takeda is one of Austria's largest pharmaceutical employers. Every day, approx. 4,500 employees contribute to ensuring that medicines from Austria are delivered to patients in more than 100 countries worldwide and that patients in Austria have access to innovative medicines from Takeda. Takeda's Austrian product portfolio helps patients in areas such as oncology, hemophilia, gastroenterology, immunology, and neuroscience. In R&D, Takeda’s activities in Austria cover the entire pharmaceutical development process from the selection of a product candidate over process and analytical development and clinical manufacturing to the market release of the product. R&D Austria is a central player in Takeda’s global R&D engine. www.takeda.com

Contact

Denisa Lazarescu
R&D Europe Communications Lead
Takeda
Donau-City-Strasse 7
1220 Vienna, Austria
denisa.lazarescu(at)takeda.com

Elvira Kainersdorfer
Cluster Manager
LISAvienna
Karl-Farkas-Gasse 18
1030 Vienna, Austria
Kainersdorfer(at)lisavienna.at

Thu, 28.11.2024 | 09:00 - 17:00

Vienna